1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Interbody Fusion Cages Market
4. Market Overview
4.1. Introduction
4.1.1. Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Interbody Fusion Cages Market Analysis and Forecast, 2017–2031
5. Key Insights
5.1. Regulatory Scenario by Region/Globally
5.2. Key Industry Events (Key Mergers & Acquisitions )
5.3. Disease Epidemiology
5.4. COVID-19 Impact Analysis
6. Global Interbody Fusion Cages Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Type, 2017–2031
6.3.1. Cervical
6.3.2. Lumbar
6.3.3. Others
6.4. Market Attractiveness Analysis, by Type
7. Global Interbody Fusion Cages Market Analysis and Forecast, by Material
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Material, 2017–2031
7.3.1. Titanium
7.3.2. Polyetheretherketone (PEEK)
7.3.3. Others
7.4. Market Attractiveness Analysis, by Material
8. Global Interbody Fusion Cages Market Analysis and Forecast, by Product
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Product, 2017–2031
8.3.1. Expandable Cages
8.3.2. Static Cages
8.4. Market Attractiveness Analysis, by Product
9. Global Interbody Fusion Cages Market Analysis and Forecast, by Indication
9.1. Introduction & Definition
9.2. Key Findings/Developments
9.3. Market Value Forecast, by Indication, 2017–2031
9.3.1. Degenerative Disc Disease
9.3.2. Spondylolisthesis
9.3.3. Spinal Tumors or Masse
9.3.4. Spinal Stenosis
9.3.5. Others
9.4. Market Attractiveness Analysis, by Indication
10. Global Interbody Fusion Cages Market Analysis and Forecast, by End-user
10.1. Introduction & Definition
10.2. Key Findings/Developments
10.3. Market Value Forecast, by End-user, 2017–2031
10.3.1. Hospitals
10.3.2. Ambulatory Surgical Centers
10.3.3. Clinics & Orthopedic Centers
10.4. Market Attractiveness Analysis, by End-user
11. Global Interbody Fusion Cages Market Analysis and Forecast, by Region
11.1. Key Findings
11.2. Market Value Forecast, by Region, 2017–2031
11.2.1. North America
11.2.2. Europe
11.2.3. Asia Pacific
11.2.4. Latin America
11.2.5. Middle East & Africa
11.3. Market Attractiveness Analysis, by Region
12. North America Interbody Fusion Cages Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Type, 2017–2031
12.2.1. Cervical
12.2.2. Lumbar
12.2.3. Others
12.3. Market Value Forecast, by Material , 2017–2031
12.3.1. Titanium
12.3.2. Polyetheretherketone (PEEK)
12.3.3. Others
12.4. Market Value Forecast, by Product, 2017–2031
12.4.1. Expandable Cages
12.4.2. Static Cages
12.5. Market Value Forecast, by Indication, 2017–2031
12.5.1. Degenerative Disc Disease
12.5.2. Spondylolisthesis
12.5.3. Spinal Tumors or Masse
12.5.4. Spinal Stenosis
12.5.5. Others
12.6. Market Value Forecast, by End-user, 2017–2031
12.6.1. Hospitals
12.6.2. Ambulatory Surgical Centers
12.6.3. Clinics & Orthopedic Centers
12.7. Market Value Forecast, by Country, 2017–2031
12.7.1. U.S.
12.7.2. Canada
12.8. Market Attractiveness Analysis
12.8.1. By Type
12.8.2. By Material
12.8.3. By Product
12.8.4. By Indication
12.8.5. By End-user
12.8.6. By Country
13. Europe Interbody Fusion Cages Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Type, 2017–2031
13.2.1. Cervical
13.2.2. Lumbar
13.2.3. Others
13.3. Market Value Forecast, by Material , 2017–2031
13.3.1. Titanium
13.3.2. Polyetheretherketone (PEEK)
13.3.3. Others
13.4. Market Value Forecast, by Product, 2017–2031
13.4.1. Expandable Cages
13.4.2. Static Cages
13.5. Market Value Forecast, by Indication, 2017–2031
13.5.1. Degenerative Disc Disease
13.5.2. Spondylolisthesis
13.5.3. Spinal Tumors or Masse
13.5.4. Spinal Stenosis
13.5.5. Others
13.6. Market Value Forecast, by End-user, 2017–2031
13.6.1. Hospitals
13.6.2. Ambulatory Surgical Centers
13.6.3. Clinics & Orthopedic Centers
13.7. Market Value Forecast, by Country/Sub-region, 2017–2031
13.7.1. Germany
13.7.2. U.K.
13.7.3. France
13.7.4. Italy
13.7.5. Spain
13.7.6. Rest of Europe
13.8. Market Attractiveness Analysis
13.8.1. By Type
13.8.2. By Material
13.8.3. By Product
13.8.4. By Indication
13.8.5. By End-user
13.8.6. By Country/Sub-region
14. Asia Pacific Interbody Fusion Cages Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Type, 2017–2031
14.2.1. Cervical
14.2.2. Lumbar
14.2.3. Others
14.3. Market Value Forecast, by Material , 2017–2031
14.3.1. Titanium
14.3.2. Polyetheretherketone (PEEK)
14.3.3. Others
14.4. Market Value Forecast, by Product, 2017–2031
14.4.1. Expandable Cages
14.4.2. Static Cages
14.5. Market Value Forecast, by Indication, 2017–2031
14.5.1. Degenerative Disc Disease
14.5.2. Spondylolisthesis
14.5.3. Spinal Tumors or Masse
14.5.4. Spinal Stenosis
14.5.5. Others
14.6. Market Value Forecast, by End-user, 2017–2031
14.6.1. Hospitals
14.6.2. Ambulatory Surgical Centers
14.6.3. Clinics & Orthopedic Centers
14.7. Market Value Forecast, by Country/Sub-region, 2017–2031
14.7.1. China
14.7.2. Japan
14.7.3. India
14.7.4. Australia & New Zealand
14.7.5. Rest of Asia Pacific
14.8. Market Attractiveness Analysis
14.8.1. By Type
14.8.2. By Material
14.8.3. By Product
14.8.4. By Indication
14.8.5. By End-user
14.8.6. By Country/Sub-region
15. Latin America Interbody Fusion Cages Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Type, 2017–2031
15.2.1. Cervical
15.2.2. Lumbar
15.2.3. Others
15.3. Market Value Forecast, by Material , 2017–2031
15.3.1. Titanium
15.3.2. Polyetheretherketone (PEEK)
15.3.3. Others
15.4. Market Value Forecast, by Product, 2017–2031
15.4.1. Expandable Cages
15.4.2. Static Cages
15.5. Market Value Forecast, by Indication, 2017–2031
15.5.1. Degenerative Disc Disease
15.5.2. Spondylolisthesis
15.5.3. Spinal Tumors or Masse
15.5.4. Spinal Stenosis
15.5.5. Others
15.6. Market Value Forecast, by End-user, 2017–2031
15.6.1. Hospitals
15.6.2. Ambulatory Surgical Centers
15.6.3. Clinics & Orthopedic Centers
15.7. Market Value Forecast, by Country/Sub-region, 2017–2031
15.7.1. Brazil
15.7.2. Mexico
15.7.3. Rest of Latin America
15.8. Market Attractiveness Analysis
15.8.1. By Type
15.8.2. By Material
15.8.3. By Product
15.8.4. By Indication
15.8.5. By End-user
15.8.6. By Country/Sub-region
16. Middle East & Africa Interbody Fusion Cages Market Analysis and Forecast
16.1. Introduction
16.1.1. Key Findings
16.2. Market Value Forecast, by Type, 2017–2031
16.2.1. Cervical
16.2.2. Lumbar
16.2.3. Others
16.3. Market Value Forecast, by Material , 2017–2031
16.3.1. Titanium
16.3.2. Polyetheretherketone (PEEK)
16.3.3. Others
16.4. Market Value Forecast, by Product, 2017–2031
16.4.1. Expandable Cages
16.4.2. Static Cages
16.5. Market Value Forecast, by Indication, 2017–2031
16.5.1. Degenerative Disc Disease
16.5.2. Spondylolisthesis
16.5.3. Spinal Tumors or Masse
16.5.4. Spinal Stenosis
16.5.5. Others
16.6. Market Value Forecast, by End-user, 2017–2031
16.6.1. Hospitals
16.6.2. Ambulatory Surgical Centers
16.6.3. Clinics & Orthopedic Centers
16.7. Market Value Forecast, by Country/Sub-region, 2017–2031
16.7.1. GCC Countries
16.7.2. South Africa
16.7.3. Rest of Middle East & Africa
16.8. Market Attractiveness Analysis
16.8.1. By Type
16.8.2. By Material
16.8.3. By Product
16.8.4. By Indication
16.8.5. By End-user
16.8.6. By Country/Sub-region
17. Competition Landscape
17.1. Market Player – Competition Matrix (by tier and size of companies)
17.2. Market Share Analysis, by Company (2022)
17.3. Company Profiles
17.3.1. Medtronic plc
17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.1.2. Product Portfolio
17.3.1.3. Financial Overview
17.3.1.4. SWOT Analysis
17.3.1.5. Strategic Overview
17.3.2. Johnson & Johnson
17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.2.2. Product Portfolio
17.3.2.3. Financial Overview
17.3.2.4. SWOT Analysis
17.3.2.5. Strategic Overview
17.3.3. Stryker Corporation
17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.3.2. Product Portfolio
17.3.3.3. Financial Overview
17.3.3.4. SWOT Analysis
17.3.3.5. Strategic Overview
17.3.4. Zimmer Biomet
17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.4.2. Product Portfolio
17.3.4.3. Financial Overview
17.3.4.4. SWOT Analysis
17.3.4.5. Strategic Overview
17.3.5. B. Braun Melsungen AG
17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.5.2. Product Portfolio
17.3.5.3. Financial Overview
17.3.5.4. SWOT Analysis
17.3.5.5. Strategic Overview
17.3.6. NuVasive, Inc.
17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.6.2. Product Portfolio
17.3.6.3. Financial Overview
17.3.6.4. SWOT Analysis
17.3.6.5. Strategic Overview
17.3.7. Alphatec Holdings, Inc.
17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.7.2. Product Portfolio
17.3.7.3. Financial Overview
17.3.7.4. SWOT Analysis
17.3.7.5. Strategic Overview
17.3.8. LASAK s.r.o.
17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.8.2. Product Portfolio
17.3.8.3. Financial Overview
17.3.8.4. SWOT Analysis
17.3.8.5. Strategic Overview
17.3.9. Xtant Medical Holdings, Inc.
17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.9.2. Product Portfolio
17.3.9.3. Financial Overview
17.3.9.4. SWOT Analysis
17.3.9.5. Strategic Overview
17.3.10. Spineology, Inc.
17.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
17.3.10.2. Product Portfolio
17.3.10.3. Financial Overview
17.3.10.4. SWOT Analysis
17.3.10.5. Strategic Overview
❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
